Oligofructose-supplemented infant cereal: 2 randomized, blinded, community-based trials in Peruvian infants

Am J Clin Nutr. 2003 Apr;77(4):937-42. doi: 10.1093/ajcn/77.4.937.

Abstract

Background: Prebiotics are nondigestible food ingredients that stimulate the growth of Bifidobacterium and other bacteria in the gastrointestinal tract. Improved gastrointestinal and other health effects have been attributed to them.

Objective: The objective of this study was to evaluate the effects of dietary supplementation with the prebiotic oligofructose with and without zinc on the prevalence of diarrhea in a community with a high burden of gastrointestinal and other infections.

Design: Two consecutive randomized, blinded, controlled clinical trials were performed in a shantytown community near Lima, Peru. The first trial compared an infant cereal supplemented with oligofructose (0.55 g/15 g cereal) with nonsupplemented cereal. During the second trial, zinc (1 mg/15 g cereal) was added to both oligofructose-supplemented and control cereals.

Results: We enrolled 282 infants in the first trial and 349 in the second. In the first trial, mean (+/- SD) days of diarrhea were 10.3 +/- 9.6 in the nonsupplemented cereal group and 9.8 +/- 11.0 in the prebiotic-supplemented cereal group (P = 0.66). In the second trial, mean days of diarrhea were 10.3 +/- 8.9 in the group consuming cereal fortified only with zinc and 9.5 +/- 8.9 in the group consuming cereal containing both zinc and prebiotics (P = 0.35). Postimmunization titers of antibody to Haemophilus influenzae type B were similar in all groups, as were gains in height, visits to clinic, hospitalizations, and use of antibiotics.

Conclusions: Cereal supplemented with prebiotics was not associated with any change in diarrhea prevalence, use of health care resources, or response to H. influenzae type B immunization. Infants and young children who continue to breast-feed may not benefit from prebiotic supplementation.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Bacterial / blood
  • Community Health Services*
  • Diarrhea / epidemiology
  • Edible Grain*
  • Female
  • Food, Fortified
  • Haemophilus Vaccines
  • Haemophilus influenzae type b / immunology
  • Humans
  • Immunization
  • Infant
  • Infant Food*
  • Male
  • Oligosaccharides / administration & dosage*
  • Peru / epidemiology
  • Probiotics
  • Zinc / administration & dosage

Substances

  • Antibodies, Bacterial
  • Haemophilus Vaccines
  • Oligosaccharides
  • oligofructose
  • Zinc